251. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study.
- Author
-
Yin Y, Lin C, Wei L, Tong J, Huang J, Tian B, Tan S, Wang Z, Yang F, Tong Y, Chen S, Hong LE, and Tan Y
- Subjects
- Humans, Male, Female, Adult, China epidemiology, Cohort Studies, Self-Injurious Behavior epidemiology, Suicidal Ideation, Hospitalization statistics & numerical data, Young Adult, Middle Aged, Clozapine therapeutic use, Schizophrenia drug therapy, Antipsychotic Agents therapeutic use, Suicide, Attempted statistics & numerical data
- Abstract
Background: Clozapine is an off-label drug used in most countries to prevent suicide in individuals with schizophrenia. However, few studies have reported real-world prescription practices. This study aimed to explore the association between a history of suicidal behavior and clozapine prescribing during eight weeks of hospitalization for individuals with early-stage schizophrenia., Methods: This observational cohort study used routine health data collected from a mental health hospital in Beijing, China. The study included 1057 inpatients who had schizophrenia onset within 3 years. History of suicidal behavior was coded from reviewing medical notes according to the Columbia Suicide Severity Rating Scale. Information on antipsychotic use during hospitalization was extracted from the prescription records. Time to clozapine use was analyzed using Cox regression models adjusted for sociodemographic and clinical covariates., Results: The prevalence rates of self-harm, suicidal behavior, and suicide attempt were 12.3%, 7.5%, and 5.4%, respectively. A history of self-harm history was positively associated with clozapine uses upon admission (4.1% vs. 0.8%, exact p = 0.009). Among those who had not used clozapine and had no clozapine contraindication, A history of suicidal behavior increased the possibility of switch to clozapine within 56 days after admission (Hazard Ratio[95% CI], 6.09[2.08-17.83]) or during hospitalization (4.18[1.62-10.78])., Conclusion: The use of clozapine for early-stage schizophrenia was more frequent among those with suicidal behavior than among those without suicidal behavior in China, although the drug instructions do not label its use for suicide risk., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF